Press Releases Items Per Page 102550 News Category FinancialGeneral Year None20252024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets Oct 23, 2008 Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder Oct 21, 2008 Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City Oct 07, 2008 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City Sep 16, 2008 Nektar Therapeutics Announces Second Quarter 2008 Results Aug 06, 2008 Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer Aug 06, 2008 Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets Jul 30, 2008 New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Molecule PEG-Oncolytics Jun 02, 2008 Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan) Jun 02, 2008 Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan) May 30, 2008 Pagination First page « first Previous page ‹ previous … Page 42 Page 43 Page 44 Page 45 Current page 46 Page 47 Page 48 Page 49 Page 50 … Next page next › Last page last »